We maintain the components of the quality management platform, such as website, online questionnaire, database of the RemiPCA Registry and the RemiPCA Alert function. The RemiPCA Registry complies with the privacy and bio-registry requirements of the health authorities (CH, UK).
The consistent and standardized recording of outcome data by all participating hospitals as well as the analysis of severe events (RemiPCA Alerts) form the basis for the continuous improvement of the application guidelines (SOP).
The participating hospitals are able to access their own data directly via the website and to carry out quality control at any time (hospital audit). The network operators carry out periodic evaluations of the overall data and inform all participating hospitals about the results, severe events and improvements of the standards (process audit).
This dynamic approach continuously optimizes "best practice" and promotes safety and quality of the procedure.
A training day on “Remifentanil PCA for labour” includes:
During the personal training day, we have the possibility to incorporate the equipment and the infrastructure of your hospital, which ensures an efficient launch on a high safety level.
Dr. David Hill presents the first regimen for the routine use of remifentanil PCA in labour at the OAA Annual Meeting in Belfast.
The first 40 patients in Switzerland at the Salem-Spital, Berne, receive remifentanil PCA based on the guideline of Dr David Hill including outcome control.
Launch of remifentanil PCA as routine labour analgesia with a systematic and continous web-based outcome control via online questionnaire.
3 hospitals join the RemiPCA SAFE Network.
Condesys Consulting develops as a sponsor the professional registry with login, advanced online questionnaire, database and live evaluation.
Poster presentation and "Pick the Poster", OAA, Edinburgh, Scotland (The launch of Remifentanil-PCA in labour in Switzerland combined with web based continuous quality control).
10 hospitals join the RemiPCA SAFE Network.
The Swiss Association of Obstetric Anaesthesia (SAOA) takes over the patronage
of the RemiPCA SAFE Network.
Outcome data are presented at the
World Congress of Anaesthesiology (WCA) in Buenos Aires
12 hospitals join the RemiPCA SAFE Network.
The RemiPCA Alert function is developed to speed up and rise the awareness of serious incidents within the network.
Pro-Con discussion is held about the routine use of remifentanil-PCA for labour at the World Congress of Regional Anaesthesia and Pain Therapy (WCRAPT) in Cape Town.
23 hospitals join the RemiPCA SAFE Network.
The network opens up to hospitals outside Switzerland with different application regimens. As a result, hospitals from Germany, Great Britain, Australia and Singapore join the network.
35 hospitals join the RemiPCA SAFE Network.
The network organizes the 1st International RemiPCA User Meeting during the OAA Annual Meeting in Brussels and the 1st International Expert and Opinion Leader Meeting during Euroanaesthesia in Geneva.
The Obstetric Anesthetists' Association (OAA) supports the publication of network data with a grant.
The Swiss Society for Anaesthesiology and Resuscitation (SGAR) and the SAOA are participating in the financing of the network.
39 hospitals join the RemiPCA SAFE Network.
Development and Operation
To obtain the login password for participation in the RemiPCA SAFE Network, please send us an E-mail with the following information:
We will provide you a specific login password for your hospital.